logo
New Astronomer CEO Addresses ‘Surreal' Reality After Coldplay Kiss Cam Concert Scandal

New Astronomer CEO Addresses ‘Surreal' Reality After Coldplay Kiss Cam Concert Scandal

Forbes2 days ago
Pete DeJoy, interim CEO of tech startup Astronomer, acknowledged the 'unusual and surreal' media attention the startup has received, in his first comments since taking over for former CEO Andy Byron, who resigned amid a viral scandal in which he was caught on a 'kiss cam' hugging an Astronomer employee, who is not his wife, at a Coldplay concert.
Former Astronomer CEO Andy Byron was caught on a "kiss cam" at a Coldplay concert with a company ... More employee who is not his wife. (Photo by) Getty Images
DeJoy, who was installed as interim CEO over the weekend, in a LinkedIn post Monday afternoon made his first public comments since the scandal sparked a social media frenzy.
DeJoy said Astronomer had received 'a level of media attention that few companies—let alone startups in our small corner of the data and AI world—ever encounter' in recent days, though he did not refer to Byron by name, nor did he specifically reference the Coldplay concert incident.
DeJoy said Astronomer is 'now a household name,' but he said he 'would never have wished for it to happen like this,' calling the heightened attention 'unusual and surreal for our team.'
In his post, DeJoy said Astronomer has 'never shied away from challenges' and said he would approach the role with a 'wholehearted commitment to taking care of our people and delivering for our customers,' thanking his team for its 'resilience.'
Before taking the interim CEO position, DeJoy, a co-founder of the company, served as its chief product officer.
Astronomer announced Saturday that Byron would step down from his role as CEO, stating the company's 'leaders are expected to set the standard in both conduct and accountability, and recently, that standard was not met.'
Byron resigned three days after he was caught on a 'kiss cam' at a Coldplay concert in Foxborough, Massachusetts, hugging Kristin Cabot, Astronomer's chief people officer, who is not his wife. Cabot is still listed as chief people officer on the company's leadership page, which now also reflects DeJoy's status as interim CEO. Once the camera cut to Byron and Cabot, Cabot broke free from his arms and covered her face as Byron moved out of frame. 'Either they're having an affair, or they're just very shy. I'm not quite sure what to do,' Coldplay's frontman Chris Martin said. The incident—viewed as a scandal that may have revealed an extramarital affair—quickly went viral on social media, sparking plenty of memes and parodies, as well as discussions about privacy. Byron has not yet commented following the incident, despite the spread of a fake statement in which he appeared to apologize and quote Coldplay lyrics. Astronomer confirmed in its statement announcing Byron's resignation he had not made a statement himself. Tangent
In the days since last week's Coldplay concert, several high-profile artists have poked fun at the incident at their own shows. Oasis frontman Liam Gallagher said at a concert in England on Sunday: 'Don't worry, we ain't got any of that Coldplay, snidey fucking camera sh—. It doesn't matter to us who you're f—ing mingling with.' Country star Morgan Wallen joked at an Arizona concert Friday that anyone who is 'here with their side chick or whatever' is 'safe.' During a concert in South Carolina on Thursday, Luke Bryan joked: 'We're gonna shine our cameras on anybody.' Coldplay acknowledged the scandal at a concert in Madison, Wisconsin, on Saturday. 'We'd like to say hello to some of you in the crowd. How we're gonna do that is we're gonna use our cameras and put some of you on the big screen,' Martin said, to laughs from the crowd.
Astronomer CEO Steps Down After Being Seen Embracing HR Chief On Coldplay Kiss Cam (Forbes)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

Yahoo

time3 minutes ago

  • Yahoo

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

BEACHWOOD, Ohio, July 23, 2025 /CNW/ -- Trailhead Biosystems, Inc. ( a biotechnology company pioneering the creation of induced pluripotent stem cell (iPSC)-derived human cells at scale for drug discovery and cell therapy, introduces TrailBio® A9 Dopaminergic Neurons, a powerful new tool available off-the-shelf for studying Parkinson's disease and other neurodegenerative conditions. A9 dopaminergic neurons play a critical role in movement regulation and are disproportionately affected in Parkinson's disease. Historically, researchers have lacked access to viable human models, relying instead on animal studies with limited relevance. With TrailBio® A9 Dopaminergic Neurons, scientists now have a human-specific platform to investigate disease mechanisms, develop therapies and accelerate drug discovery. "TrailBio® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems. "These cells enable researchers to study the vulnerabilities of A9 neurons, helping drive progress toward more effective treatments." "For decades, the lack of human A9 neurons has limited our ability to truly understand Parkinson's disease," added Dr. Nooshin Amini, Scientific Director at Trailhead Biosystems. "Now, with TrailBio® A9 Dopaminergic Neurons, researchers can directly study the exact cells that are most affected, offering hope for groundbreaking insights and future therapies." About Trailhead Biosystems Trailhead Biosystems, Inc. is pioneering an informatics-based approach in regenerative medicine and drug discovery. Founded in 2015 as a spinout from the Cleveland Clinic and Case Western Reserve University, Trailhead emerged from the research of CSO/CTO and founder Dr. Jan Jensen. Trailhead creates optimized human cells at scale with its proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, integrating advanced mathematical modeling with high-throughput robotic manufacturing. This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio® A9 Dopaminergic Neurons represent one of many specialized human cell types emerging from this platform, with additional cell models expected in the near future. Learn more about Trailhead Biosystems, TrailBio® A9 Dopaminergic Neurons and HD-DoE® at For more information, please contact: Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@ View original content to download multimedia: SOURCE Trailhead Biosystems Inc View original content to download multimedia:

S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club
S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club

Yahoo

time3 minutes ago

  • Yahoo

S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club

Block, Jack Dorsey's Bitcoin-focused payments company, is set to join the S&P 500 on Wednesday, a milestone moment for both the company and and foray further into crypto for the benchmark index. Block (XYZ), which was rebranded from Square in 2021, is the second blockchain company to join the club after cryptocurrency exchange Coinbase Global (COIN) was added to the index in mid-May. That means index fund investors will get a modest bump in exposure to the world's largest cryptocurrency bitcoin (BTCUSD). The company takes the spot vacated by Hess Corp., which was acquired by Chevron (CVX) in a deal that closed July 18. It's the third addition of the month, following The Trade Desk (TTD) and Datadog (DDOG). Since the announcement of Block's inclusion late Friday, the shares have risen 9%. Block's stock has benefited from an index effect, which refers to directional pressure on stocks when a company is added to, or removed from, the S&P 500 and other indexes. The most recent research report on the matter from S&P Dow Jones Indices, which studied the price impact of index additions and deletions from 1995 to June 2021, showed that it isn't always much of a force. The median excess returns—defined here as the difference between a stock's total return and that of the broader index—of stocks added to the index, measured from the announcement date to the effective date, was about 8% from 1995 to 1999. From 2000 to 2010, that number shrank to 3.6%, and was essentially nonexistent from 2011 to 2021. And even if an index effect shows up ahead of the official inclusion or deletion date, according to a McKinsey study, the premium or discount has a tendency to dissipate within a few months. What's new can get old pretty fast. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Texas Instruments shares sink as tariff risks cloud chip demand outlook
Texas Instruments shares sink as tariff risks cloud chip demand outlook

Yahoo

time3 minutes ago

  • Yahoo

Texas Instruments shares sink as tariff risks cloud chip demand outlook

(Reuters) -Texas Instruments shares slumped nearly 12% in premarket trading on Wednesday, after its quarterly profit forecast indicated a hit to demand for its analog chips that stoked investor fears of tariff-related disruptions. The dour third-quarter profit forecast contrasts with its earlier hopes for a strong rebound in chip demand, increasing concerns about tariff impacts and tempering investor confidence. In response to analysts' questions on a post-earnings call about whether tariffs were prompting customers to pull in orders and bumping up revenue, TI CEO Haviv Ilan said he "can't rule out the possibility". "(TI's) tone has shifted markedly vs last quarter's call as well as vs management's intra-quarter commentary, with seemingly more caution around the geopolitical and tariff environment," said Bernstein analyst, Stacy Rasgon, adding that the shift "felt somewhat sudden". Chipmakers like TI are not directly affected by Trump's higher tariffs yet, but rising costs for chip-making tools and reduced spending by some customers are starting to have an impact. This was evident in the broader semiconductor industry, with both ASML, the biggest supplier of chip-making equipment globally, and TSMC, the world's biggest chipmaking factory, last week, warned about tariff-related uncertainty. "The impact of tariffs/trade is beginning to emerge and we anticipate a continuation of a slightly weaker than seasonal demand environment as the year progresses due to the impact of tariffs," said analysts at J.P. Morgan. Some analysts also expressed concerns about pressure to TI's margins due to the company's rising investments to expand its U.S. manufacturing footprint. Following the results, at least six brokerages cut price targets on the stock, while three raised, as per data compiled by LSEG. The firm is up about 15%, while peer Analog Devices has gained around 11%, so far this year. TI has a 12-month forward price-to-earnings ratio of 34.66, compared to Analog Devices' 27.64.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store